Job description: We want you to feel inspired every day. We’re future-focused and our business is growing. We succeed together through passion, commitment, and teamwork, and so can you. We are currently recruiting for a Laboratory Support Assistant to join the Laboratory Management Team (LMT) team. The purpose of this role is to carry out routine tasks to aid and support the smooth running of the day-to-day activities of the laboratory including waste management and stock control. Our Laboratory Management Team is responsible for overseeing the smooth running of the laboratory suites. The team is accountable for the smooth running of the day-to-day activities of the laboratories including cleaning, waste management, stock control and overseeing equipment servicing and calibration. Your responsibilities in this role would be: The timely removal and decontamination of clinical waste from the laboratory suites ensuring a compliant working environment. To prepare and maintain disinfectant solutions to the correct concentration appropriate for use. To collect and clean used laboratory glassware and general laboratory items. Maintain consumable stock levels for the laboratories. Regular cleaning of the laboratories and associated equipment Ensure clear concise information is passed onto team members. Be the point of contact for laboratory enquires by Scientists regarding waste control and consumable requests. We are looking for: A minimum of GCSE grade 4-9 in English and Mathematics or equivalent level. A good standard or English both written and spoken. The ability to follow standard operating procedures. A team player with a positive willing approach. Proactive and well organised Good attention to detail A good standard of computer literacy. Please note this is not considered an undergraduate career path into Research & Development or Manufacturing at OXB. Please see Scientist II or Biotechnologist or other similar opportunities on our career site for these types of roles. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. What’s in it for you: Highly competitive total reward packages Wellbeing programmes Development opportunities Welcoming, friendly, supportive colleagues A diverse and inclusive working environment Our values are: Responsible, Responsive, Resilient, Respect State of the art laboratory and manufacturing facilities We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you. Collaborate. Contribute. Change lives We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.